Current opinion in rheumatology

Keyphrases

Publications

volume 36, number 3, 2024

Hiroshi Kato, J Michelle Kahlenberg
Emerging biologic therapies for systemic lupus erythematosus. Current opinion in rheumatology 36 (3) (2024)
Elizabeth Park, Joan Bathon
Cardiovascular complications of rheumatoid arthritis. Current opinion in rheumatology 36 (3) (2024)
Beth I Wallace, Laura Cooney, David A Fox
New molecular targets in the treatment of rheumatoid arthritis. Current opinion in rheumatology 36 (3) (2024)
Kevin D Deane
Rheumatoid arthritis: prediction of future clinically-apparent disease, and prevention. Current opinion in rheumatology 36 (3) (2024)
Günter Steiner, René E M Toes
Autoantibodies in rheumatoid arthritis - rheumatoid factor, anticitrullinated protein antibodies and beyond. Current opinion in rheumatology 36 (3) (2024)
Kevin D Deane
Rheumatoid arthritis: prediction of future clinically-apparent disease, and prevention. Current opinion in rheumatology 36 (3) (2024)
Silvia Sirotti, Robert Terkeltaub, Georgios Filippou
Describing calcium pyrophosphate deposition: undoing the tower of Babel! Current opinion in rheumatology 36 (3) (2024)
Nathan M Johnson, Fotios Koumpouras
Chimeric antigen receptors: "CARs" in the fast lane for rheumatology. Current opinion in rheumatology 36 (3) (2024)
David A Fox
Rheumatoid arthritis - the challenge of heterogeneity. Current opinion in rheumatology 36 (3) (2024)
Jonathan D D'Gama, Bonnie L Bermas
Safety of biologic agents for the management of rheumatic diseases during pregnancy. Current opinion in rheumatology 36 (3) (2024)
Yuting Qin, Jianyang Ma, Carola G Vinuesa
Monogenic lupus: insights into disease pathogenesis and therapeutic opportunities. Current opinion in rheumatology 36 (3) (2024)
Elena Myasoedova, Eric L Matteson
Updates on interstitial lung disease and other selected extra-articular manifestations of rheumatoid arthritis. Current opinion in rheumatology 36 (3) (2024)
Benjamin R Wagner, Panduranga S Rao
Sodium-glucose cotransporter 2 inhibitors: are they ready for prime time in the management of lupus nephritis? Current opinion in rheumatology 36 (3) (2024)
Kevin D Deane
Rheumatoid arthritis: prediction of future clinically-apparent disease, and prevention. Current opinion in rheumatology 36 (3) (2024)

volume 36, number 4, 2024

Philip S Helliwell
50 years of spondyloarthritis: a look back and a look ahead. Current opinion in rheumatology 36 (4) (2024)
Philip S Helliwell
50 years of spondyloarthritis: a look back and a look ahead. Current opinion in rheumatology 36 (4) (2024)
Mathieu Choufani, Jonathan Kay, Joerg Ermann
Axial spondyloarthritis guidelines - aiming for maximum impact. Current opinion in rheumatology 36 (4) (2024)
Manouk de Hooge, Désirée van der Heijde
Disease modification in axial spondyloarthritis - still a controversy? Current opinion in rheumatology 36 (4) (2024)
Fardina Malik, Michael H Weisman
Sacroiliitis in inflammatory bowel disease. Current opinion in rheumatology 36 (4) (2024)
Lisa C Adams, Keno K Bressem, Denis Poddubnyy
Artificial intelligence and machine learning in axial spondyloarthritis. Current opinion in rheumatology 36 (4) (2024)
Manouk de Hooge, Désirée van der Heijde
Disease modification in axial spondyloarthritis - still a controversy? Current opinion in rheumatology 36 (4) (2024)
Fardina Malik, Michael H Weisman
Sacroiliitis in inflammatory bowel disease. Current opinion in rheumatology 36 (4) (2024)
Charles Sutherland, Angelo L Gaffo
Investigating gout flares: beyond a definition. Current opinion in rheumatology 36 (4) (2024)
Hemalatha Srinivasalu, Jessica Simpson, Matthew L Stoll
Drug therapy in juvenile spondyloarthritis. Current opinion in rheumatology 36 (4) (2024)
Mathieu Choufani, Jonathan Kay, Joerg Ermann
Axial spondyloarthritis guidelines - aiming for maximum impact. Current opinion in rheumatology 36 (4) (2024)
Lisa C Adams, Keno K Bressem, Denis Poddubnyy
Artificial intelligence and machine learning in axial spondyloarthritis. Current opinion in rheumatology 36 (4) (2024)
Fardina Malik, Michael H Weisman
Sacroiliitis in inflammatory bowel disease. Current opinion in rheumatology 36 (4) (2024)
Hemalatha Srinivasalu, Jessica Simpson, Matthew L Stoll
Drug therapy in juvenile spondyloarthritis. Current opinion in rheumatology 36 (4) (2024)
Hemalatha Srinivasalu, Jessica Simpson, Matthew L Stoll
Drug therapy in juvenile spondyloarthritis. Current opinion in rheumatology 36 (4) (2024)
Philip J Mease
Navigating the complexity of pain in psoriatic arthritis and axial spondyloarthritis. Current opinion in rheumatology 36 (4) (2024)
Emily K Pender, Brian Kirby
An update on topical therapies for psoriasis. Current opinion in rheumatology 36 (4) (2024)
Emily K Pender, Brian Kirby
An update on topical therapies for psoriasis. Current opinion in rheumatology 36 (4) (2024)
Emily K Pender, Brian Kirby
An update on topical therapies for psoriasis. Current opinion in rheumatology 36 (4) (2024)
Philip J Mease
Navigating the complexity of pain in psoriatic arthritis and axial spondyloarthritis. Current opinion in rheumatology 36 (4) (2024)
Mathieu Choufani, Jonathan Kay, Joerg Ermann
Axial spondyloarthritis guidelines - aiming for maximum impact. Current opinion in rheumatology 36 (4) (2024)
Manouk de Hooge, Désirée van der Heijde
Disease modification in axial spondyloarthritis - still a controversy? Current opinion in rheumatology 36 (4) (2024)
Philip J Mease
Navigating the complexity of pain in psoriatic arthritis and axial spondyloarthritis. Current opinion in rheumatology 36 (4) (2024)
Charles Sutherland, Angelo L Gaffo
Investigating gout flares: beyond a definition. Current opinion in rheumatology 36 (4) (2024)
Lisa C Adams, Keno K Bressem, Denis Poddubnyy
Artificial intelligence and machine learning in axial spondyloarthritis. Current opinion in rheumatology 36 (4) (2024)
Charles Sutherland, Angelo L Gaffo
Investigating gout flares: beyond a definition. Current opinion in rheumatology 36 (4) (2024)
Philip S Helliwell
50 years of spondyloarthritis: a look back and a look ahead. Current opinion in rheumatology 36 (4) (2024)

volume 36, number 5, 2024

Elena Galli, Francesco Muratore, Kenneth J Warrington
Current management of giant cell arteritis and its complications. Current opinion in rheumatology 36 (5) (2024)
Katherine Chakrabarti, W Joseph McCune
SGLT-2 inhibitors: new horizons for rheumatologists. Current opinion in rheumatology 36 (5) (2024)
Katherine Chakrabarti, W Joseph McCune
SGLT-2 inhibitors: new horizons for rheumatologists. Current opinion in rheumatology 36 (5) (2024)
Katherine Chakrabarti, W Joseph McCune
SGLT-2 inhibitors: new horizons for rheumatologists. Current opinion in rheumatology 36 (5) (2024)
Anne M Sage, Sarah L N Clarke, Athimalaipet V Ramanan
Novel therapies in juvenile idiopathic arthritis. Current opinion in rheumatology 36 (5) (2024)
Ellen Cody, Hermine I Brunner
Renal disease in pediatric rheumatology. Current opinion in rheumatology 36 (5) (2024)
Clovis A Silva, Nadia E Aikawa, Eloisa Bonfa
Updates in the care and management of children and adolescents with systemic lupus erythematosus. Current opinion in rheumatology 36 (5) (2024)
Jessica L Bloom, Eveline Y Wu
Update on antineutrophil cytoplasmic autoantibody vasculitis in children. Current opinion in rheumatology 36 (5) (2024)
Katherine Chakrabarti, W Joseph McCune
SGLT-2 inhibitors: new horizons for rheumatologists. Current opinion in rheumatology 36 (5) (2024)